Chulabhorn Royal Academy and the Faculty of Pharmaceutical Science at Chulalongkorn University have introduced Thailand’s first Favipiravir syrup for Covid-infected children and patients with swallowing difficulties.
CRA Secretary-General Nithi Mahanonda said that during the present wave of Covi-19, 10 percent of patients were children and to survive they would need antiviral drug Favipiravir within four days after developing severe symptoms.
Favipiravir has been commonly used to treat influenza but studies have shown it can alleviate severe symptoms of Covid-19 in the early stages.
The syrup, a clear orange-colored liquid with a raspberry flavor, comes in two bottle sizes – 800 milligrams in 60 milliliters. and 1,800 mg. in 135 ml. The patients are instructed to take it when their stomachs are empty, two times a day.
According to him, Chulabhorn Hospital is capable of producing and distributing Favipiravir syrup to about 300 patients per week. CRA is ready to share the formula of the syrup with any hospitals that are capable of producing it with quality control.
Medical personnel and hospitals can seek the syrup via Favipiravir.cra.ac.th.